Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunogenicity of SARS-CoV-2 Vaccine in Kidney Transplant Recipients: A Cross-Sectional Study in Korea

Published:2023 Issue:5 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Song Seung Hwan¹^ORCID,Chung Ku Yong¹^ORCID,Jee Yongho²^ORCID,Chung Hae-Sun³^ORCID,Kim Kina⁴^ORCID,Minn Dohsik⁴^ORCID,Kim Soo-Kyung³^ORCID

Affiliation:

1. Department of Surgery, Ewha Womans University College of Medicine, Seoul, Korea.

2. Advanced Biomedical Research Institute, Ewha Womans University Seoul Hospital, Seoul, Korea.

3. Department of Laboratory Medicine, Ewha Womans University College of Medicine, Seoul, Korea.

4. Department of Diagnostic Immunology, Seegene Medical Foundation, Seoul, Korea.

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e22

Reference24 articles.

1. Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

2. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

3. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

4. Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients

5. COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review;Vaccines;2023-11-25

2. Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023;Journal of Korean Medical Science;2023

3. Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant;Journal of Korean Medical Science;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3